Samrat Pharmachem Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
112.80 Cr.
|
P/BV
|
1.79
|
Book Value (Rs.)
|
204.37
|
52 Week High/Low (Rs.)
|
604/320
|
FV/ML
|
10/1
|
P/E(X)
|
6.78
|
Bookclosure
|
25/09/2023
|
EPS (Rs.)
|
53.83
|
Div Yield (%)
|
0.27
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 53.83 | 55.62 | 17.26 | 13.71 | 4.97 |
Diluted EPS (Rs.) | 53.83 | 55.62 | 17.26 | 13.71 | 4.97 |
Cash EPS (Rs.) | 55.91 | 57.54 | 18.86 | 15.09 | 6.32 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 204.37 | 151.54 | 95.92 | 78.66 | 64.95 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 204.37 | 151.54 | 95.92 | 78.66 | 64.95 |
Dividend / Share (Rs.) | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Revenue From Operations / Share (Rs.) | 1005.42 | 717.91 | 579.40 | 444.87 | 359.70 |
PBDIT / Share (Rs.) | 78.99 | 80.57 | 29.55 | 23.31 | 11.76 |
PBIT / Share (Rs.) | 76.91 | 78.65 | 27.96 | 21.93 | 10.41 |
PBT / Share (Rs.) | 72.92 | 76.39 | 23.77 | 18.72 | 6.98 |
Net Profit / Share (Rs.) | 53.83 | 55.62 | 17.26 | 13.71 | 4.97 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 7.85 | 11.22 | 5.10 | 5.23 | 3.26 |
PBIT Margin (%) | 7.64 | 10.95 | 4.82 | 4.92 | 2.89 |
PBT Margin (%) | 7.25 | 10.64 | 4.10 | 4.20 | 1.94 |
Net Profit Margin (%) | 5.35 | 7.74 | 2.97 | 3.08 | 1.38 |
Return on Networth / Equity (%) | 26.33 | 36.70 | 17.99 | 17.43 | 7.65 |
Return on Capital Employeed (%) | 37.48 | 51.39 | 28.72 | 27.71 | 15.38 |
Return On Assets (%) | 14.31 | 20.31 | 9.29 | 7.26 | 3.81 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Total Debt / Equity (X) | 0.29 | 0.16 | 0.29 | 0.37 | 0.30 |
Asset Turnover Ratio (%) | 3.09 | 3.12 | 3.09 | 2.79 | 2.74 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.87 | 1.98 | 1.73 | 1.47 | 1.69 |
Quick Ratio (X) | 1.25 | 1.65 | 1.31 | 0.91 | 1.28 |
Inventory Turnover Ratio (X) | 12.82 | 15.98 | 10.74 | 9.87 | 14.01 |
Dividend Payout Ratio (NP) (%) | 1.85 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Payout Ratio (CP) (%) | 1.78 | 0.00 | 0.00 | 0.00 | 0.00 |
Earning Retention Ratio (%) | 98.15 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash Earning Retention Ratio (%) | 98.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 19.81 | 36.91 | 7.15 | 7.36 | 3.43 |
Interest Coverage Ratio (Post Tax) (%) | 14.50 | 26.51 | 5.19 | 5.34 | 2.45 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 121.43 | 140.04 | 48.27 | 26.43 | 26.90 |
EV / Net Operating Revenue (X) | 0.39 | 0.63 | 0.26 | 0.19 | 0.24 |
EV / EBITDA (X) | 4.98 | 5.63 | 5.29 | 3.67 | 7.40 |
MarketCap / Net Operating Revenue (X) | 0.36 | 0.67 | 0.23 | 0.13 | 0.20 |
Retention Ratios (%) | 98.14 | 0.00 | 0.00 | 0.00 | 0.00 |
Price / BV (X) | 1.82 | 3.20 | 1.42 | 0.76 | 1.15 |
Price / Net Operating Revenue (X) | 0.36 | 0.67 | 0.23 | 0.13 | 0.20 |
EarningsYield | 0.14 | 0.11 | 0.12 | 0.22 | 0.06 |